M. Hochmair - Vienna North Hosp, Karl Landsteiner Inst Lung Res & Pulm Oncol

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1394Tip KRYSTAL-7: A Phase III Study of First-Line Adagrasib Plus Pembrolizumab Versus Pembrolizumab Alone in Patients with Advanced NSCLC with KRASG12C Mutation

M.C. Garassino, P.A. Jänne, F. Barlesi,A.I. Spira, T.S.K. Mok,M. Hochmair, K.J. O'Byrne, E. Felip,S-W. Kim, F. Cappuzzo, J. Naidoo, M. Safadi, B. Wamil, J. He, M. Reck

Annals of Oncology (2024)

引用0浏览0引用

OA13.04 ALINA Safety Results: Adjuvant Alectinib Vs Chemotherapy in Patients with Resected ALK+ Non-Small Cell Lung Cancer (NSCLC)

H. Horinouchi, B.J. Solomon, Y.-L. Wu, F. Barlesi, M. Nishio, J.S. Ahn, D.H. Lee, J.-S. Lee, W. Zhong,M. Hochmair, I. Bondarenko, D. Planchard,A. Rittmeyer, B. Ding, T. Ruf, L. Adler, A. Scalori, R. Dziadziuszko

Journal of Thoracic Oncologyno. 10 (2024)

引用0浏览0引用

P1.12B.03 Real-World Outcomes of 2L ALK TKIs Following 1L Brigatinib for Patients with ALK+ NSCLC from the ALTA-1L Trial

M.-J. Ahn, A. Delmonte, S. Ghosh,M. Hochmair, T.-Y. Yang, J.C.-H. Yang, J.-Y. Han,K. Holmskov Hansen, Y. Wu, Y. Wan, H.M. Lin, J. Kretz, B. Hupf, A.M. Kurec,E.N. Churchill,R.J. Fram, C.J. Cabasag, V. Goriya, Y. Zhao, E. Gemmen, M.R. García Campelo

Journal of Thoracic Oncologyno. 10 (2024)

引用0浏览0引用

1392Tip Phase III Study of Pembrolizumab Plus MK-1084 Vs Pembrolizumab Plus Placebo As First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRAS G12C Mutation and PD-L1 Tumour Proportion Score (TPS) ≥50%: MK-1084-004